What is the main business of Fertina?

The main business activity of Fertina focuses on business and other management consultancy activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 18, 2015.

Where is the headquarters located?

The headquarters is located at: ul. Dzika 15, 00-172 Warszawa.

What is the share capital?

The share capital of the company is PLN 5,100 (approx. $1,378).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

The company reported a revenue of $9,454 in 2025, which is an increase of 91.6% compared to 2024.

Yes, in 2025 the company was profitable, achieving a net profit of $6,686, meaning the company increased its profit by 233.9%.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to $2,768 in 2025, representing 100% of all operating expenses.

Fertinasp. z o.o.

Business and other management consultancy activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2015-09-18

Share capital

5,100.00 PLN

Activity description

Fertina is a fertility clinic in Warsaw, providing diagnostics and individually managed treatment. Its services include semen analysis and fallopian tube patency testing, insemination, IVF and prenatal screening.

Registered address

ul. Dzika 15/C/u/4, 00-172 Warszawa, Poland

Website

fertina.pl

Phone

Social media

Financials

Revenue history

Filing timeliness

Financial statements were filed on time, on average 54 days early.

202515/07/2026
202410/07/2025
202306/06/2024
202229/04/2023
202104/07/2022
202009/04/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 9.45kMedianUSD 66.59kAverageUSD 1.19m

Net profit

This companyUSD 6.69kMedianUSD 1.80kAverageUSD 66.86k

Operating costs

This companyUSD 2.77kMedianUSD 50.38kAverageUSD 1.01m

Assets

This companyUSD 22.83kMedianUSD 69.63kAverageUSD 2.60m

News

2025-06-14

Autologous Intrauterine Infusion with Platelet-Rich Plasma (PRP)

2024-05-25

Government Refund Program for In Vitro Fertilization 2024

2023-09-27

Ultrasound Examination of Endometriosis

Industry

Business and other management consultancy activities (70.22.Z)Primary

Offer

Infertility treatment
Fallopian tube patency testing
Semen analysis
Cycle monitoring
In vitro fertilisation
Insemination
Prenatal testing
Gynaecological ultrasound

Website technology

Online shop

WooCommerce

Website

WordPress

Analytics and marketing

Google Tag Manager

Authorized Representatives

Alicja Bednarowska Flisiak – Management Board Member

Anna Kucińska Chahwan – Management Board Member

Dariusz Piotr Flisiak – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Alicja Bednarowska Flisiakage 52	17	$459.21	33.3333%
Dariusz Piotr Flisiakage 52	17	$459.21	33.3333%
Anna Małgorzata Kucińska Chahwanage 53	17	$459.21	33.3333%

Alicja Bednarowska Flisiak and Dariusz Piotr Flisiak hold a combined 66.7% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

	Name	Revenue	Website
	Igamedsp. z o.o.	$6,952.56	igamed.pl

FAQ

Last updated: 2026-07-15